We are live on
!
Find out more
PCM
Poehling Capital Management Portfolio holdings
AUM
$466M
1-Year Est. Return
24.17%
This Fund
S&P 500
This Quarter
Est. Return
+2.1%
1 Year Est. Return
+24.17%
3 Year Est. Return
+70.93%
5 Year Est. Return
+69.6%
10 Year Est. Return
–
AUM
$296M
AUM Growth
-$774K
(-0.26%)
Cap. Flow
-$3.22M
Cap. Flow
% of AUM
-1.09%
Top 10 Holdings %
Top 10 Hldgs %
34.89%
Holding
126
New
4
Increased
23
Reduced
73
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$5.15M |
| 2 |
Markel Group
MKL
|
+$2.8M |
| 3 |
3M
MMM
|
+$2.12M |
| 4 |
Keurig Dr Pepper
KDP
|
+$1.98M |
| 5 |
HF Sinclair
DINO
|
+$1.21M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$3.43M |
| 2 |
Philip Morris
PM
|
+$1.79M |
| 3 |
Intel
INTC
|
+$1.62M |
| 4 |
Apollo Global Management
APO
|
+$1.61M |
| 5 |
Unilever
UL
|
+$1.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 34.6% |
| 2 | Healthcare | 17.46% |
| 3 | Communication Services | 10.1% |
| 4 | Technology | 9.94% |
| 5 | Energy | 7.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Berkshire Hathaway Class B
BRK.B
$1.12T
| $21.8M | 7.38% |
64,048
-984
| -2% | -$321K |
|
|
2
Markel Group
MKL
$23.4B
| $14.5M | 4.9% |
10,484
+2,089
| +25% | +$2.8M |
|
3
Apple
AAPL
$4.52T
| $11.9M | 4.04% |
61,581
-1,326
| -2% | -$231K |
|
|
SCHW
4
Charles Schwab
SCHW
$185B
| $10.5M | 3.56% |
185,903
+98,248
| +112% | +$5.15M |
|
5
Microsoft
MSFT
$3.66T
| $8.09M | 2.73% |
23,749
-417
| -2% | -$131K |
|
6
Viatris
VTRS
$20.6B
| $7.87M | 2.66% |
788,111
-44,100
| -5% | -$421K |
|
7
Organon & Co
OGN
$3.56B
| $7.45M | 2.52% |
357,824
+2,157
| +0.6% | +$46.9K |
|
8
Alphabet (Google) Class C
GOOG
$4.59T
| $7.17M | 2.42% |
59,297
-2,010
| -3% | -$233K |
|
9
Warner Bros
WBD
$64.7B
| $7M | 2.36% |
558,106
-18,892
| -3% | -$245K |
|
10
Cannae Holdings
CNNE
$660M
| $6.88M | 2.32% |
340,313
+26,321
| +8% | +$505K |
|
|
WBA
11
DELISTED
Walgreens Boots Alliance
WBA
| $6.85M | 2.31% |
240,274
+19,526
| +9% | +$636K |
|
12
Occidental Petroleum
OXY
$54.8B
| $6.41M | 2.16% |
108,960
-2,044
| -2% | -$123K |
|
13
Wells Fargo
WFC
$267B
| $6.33M | 2.14% |
148,276
-3,367
| -2% | -$136K |
|
|
14
3M
MMM
$93.6B
| $6.22M | 2.1% |
74,327
+24,936
| +50% | +$2.12M |
|
15
CVS Health
CVS
$133B
| $6M | 2.03% |
86,764
+182
| +0.2% | +$12.9K |
|
16
Mastercard
MA
$500B
| $5.79M | 1.96% |
14,725
-279
| -2% | -$105K |
|
17
Bristol-Myers Squibb
BMY
$135B
| $5.72M | 1.93% |
62,910
+1,311
| +2% | +$87.9K |
|
18
Visa
V
$690B
| $5.39M | 1.82% |
22,715
-405
| -2% | -$92.7K |
|
19
State Street Energy Select Sector SPDR ETF
XLE
$38.4B
| $5.32M | 1.8% |
131,184
-3,652
| -3% | -$149K |
|
20
Marathon Petroleum
MPC
$91.3B
| $5.06M | 1.71% |
43,378
-1,200
| -3% | -$140K |
|
21
Medtronic
MDT
$110B
| $4.94M | 1.67% |
56,035
-4,526
| -7% | -$390K |
|
|
PARAA
22
DELISTED
Paramount Global Class A
PARAA
| $4.68M | 1.58% |
294,215
+38,930
| +15% | +$808K |
|
23
Invesco
IVZ
$14.1B
| $4.25M | 1.44% |
252,794
-4,613
| -2% | -$74.2K |
|
24
British American Tobacco
BTI
$128B
| $4.08M | 1.38% |
123,032
+7,565
| +7% | +$259K |
|
25
Jefferies Financial Group
JEF
$12.8B
| $4.06M | 1.37% |
122,297
+319
| +0.3% | +$9.96K |
|
Similar funds
UC
JHC
HP
ACGA
PC
VCM
SP
KWS
Poehling Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Poehling Capital Management held 126 positions worth $296M, down 0.26% from $297M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Poehling Capital Management's Q2 2023 filing shows 4 new, 23 increased, 73 reduced and 4 closed positions. Its largest new stake was Keurig Dr Pepper: 60,209 shares worth $1.88M. The largest sale was AbbVie, an estimated $3.43M.
By sector, the portfolio is most concentrated in Financials at 35% of assets, up from 31% a quarter earlier, followed by Healthcare and Communication Services.
- Poehling Capital Management's largest Q2 2023 buy was Keurig Dr Pepper: 60,209 shares worth $1.88M.
- Poehling Capital Management added most to Charles Schwab in Q2 2023, an estimated $5.15M increase.
- Poehling Capital Management's biggest Q2 2023 reduction was AbbVie, cutting an estimated $3.43M.
- Poehling Capital Management fully exited Unilever in Q2 2023, selling an estimated $1.55M.
- Poehling Capital Management's ten largest holdings make up 35% of its $296M portfolio in Q2 2023.
- Poehling Capital Management opened 4 new positions and closed 4 in Q2 2023.
- Poehling Capital Management's portfolio value fell 0.26% quarter-over-quarter to $296M.
Based on Poehling Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.